Comparing stimulation doses for IVF with genetic testing
Part of Women’s health & pregnancy clinical trials.
This trial tests two different intensities of ovarian stimulation for women undergoing IVF with genetic testing of embryos. It aims to see which approach leads to more healthy embryos ready for transfer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been trying to get pregnant and need IVF.
- You are planning to test embryos for genetic health.
- Your AMH level (a measure of egg reserve) is between 1.5 and 3.5 ng/ml.
- Your body mass index (BMI) is between 18.5 and 30.
- You do not have a severe male infertility factor requiring surgical sperm extraction.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a hormone treatment (hMG) works for people doing IVF with genetic screening of embryos. It may help if you have normal ovarian reserve and are not using donor sperm.
This trial compares two starting doses of follicle-stimulating hormone (FSH) during in vitro fertilization (IVF) to see which works better. FSH helps your ovaries produce eggs, and the study aims to find the best dose for women with good fertility prospects.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial tests whether a lower or higher dose of follicle-stimulating hormone (FSH) works better for women with normal egg supply. If you are starting your first or second IVF cycle, you may be able to join.
This trial tests a fixed dose of the hormone follitropin delta (Rekovelle) to stimulate the ovaries before intrauterine insemination (IUI). It aims to see if this approach works well for women with regular cycles who are starting IUI for the first time.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
Hear when a new Fertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.